Clincosm LogoSign in Get a demo

Residual Disease

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)

Recruiting
  • Breast Cancer Female
  • +7 more
  • DC1 Vaccine
  • WOKVAC Vaccine
  • Tampa, Florida
  • +6 more
Apr 4, 2022

Residual Disease Trial in Taipei (Cold snaring polypectomy/ Cold EMR/Hot EMR)

Recruiting
  • Residual Disease
  • Cold snaring polypectomy/ Cold EMR/Hot EMR
  • Taipei, Taiwan (roc), Taiwan
    National Taiwan University Hospital
Nov 2, 2021

Triple Negative Breast Cancer, Residual Disease Trial in Boston (Niraparib, Radiation Therapy)

Recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

Residual Disease, Aggressive Periodontitis Trial in Sao Jose dos Campos (procedure, other, dietary supplement, drug)

Completed
Has Results
  • Residual Disease
  • Aggressive Periodontitis
  • Open flap debridement
  • +3 more
  • Sao Jose dos Campos, SP, Brazil
    College of Dentistry - São José dos Campos, Sao Paulo State Univ
Nov 10, 2020

Colorectal Cancer, Residual Disease Trial in Tampere (blood draw)

Active, not recruiting
  • Colorectal Cancer
  • Residual Disease
  • blood draw
  • Tampere, Finland
    Tampere University Hospital
Oct 26, 2020